Literature DB >> 25627464

Extensively drug-resistant carbapenemase-producing Enterobacteriaceae: an emerging challenge for clinicians and healthcare systems.

G M Rossolini1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25627464     DOI： 10.1111/joim.12350

Source DB:  PubMed          Journal:  J Intern Med        ISSN： 0954-6820            Impact factor:   8.989


× No keyword cloud information.
  10 in total

1.  Colistin Resistance Caused by Inactivation of the MgrB Regulator Is Not Associated with Decreased Virulence of Sequence Type 258 KPC Carbapenemase-Producing Klebsiella pneumoniae.

Authors:  Fabio Arena; Lucia Henrici De Angelis; Antonio Cannatelli; Vincenzo Di Pilato; Marina Amorese; Marco Maria D'Andrea; Tommaso Giani; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

2.  mcr-1.2, a New mcr Variant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512.

Authors:  Vincenzo Di Pilato; Fabio Arena; Carlo Tascini; Antonio Cannatelli; Lucia Henrici De Angelis; Simona Fortunato; Tommaso Giani; Francesco Menichetti; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

3.  Coexistence of mcr-1 and blaNDM-1 in Escherichia coli from Venezuela.

Authors:  Jose F Delgado-Blas; Cristina M Ovejero; Lorena Abadia-Patiño; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

4.  Ceftazidime-Avibactam Resistance Associated with Increased bla KPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae.

Authors:  Marco Coppi; Vincenzo Di Pilato; Francesco Monaco; Tommaso Giani; Pier Giulio Conaldi; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

5.  Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients.

Authors:  Tommaso Giani; Alberto Antonelli; Mariasofia Caltagirone; Carola Mauri; Jessica Nicchi; Fabio Arena; Elisabetta Nucleo; Silvia Bracco; Annalisa Pantosti; Francesco Luzzaro; Laura Pagani; Gian Maria Rossolini
Journal:  Euro Surveill       Date:  2017-08-03

Review 6.  Infections caused by carbapenem-resistant Klebsiella pneumoniae with hypermucoviscous phenotype: A case report and literature review.

Authors:  Fabio Arena; Lucia Henrici De Angelis; Marco Maria D'Andrea; Antonio Cannatelli; Lucina Fossati; Vincenzo Di Pilato; Tommaso Giani; Rossana Cavallo; Gian Maria Rossolini
Journal:  Virulence       Date:  2017-02-23       Impact factor: 5.882

7.  The Emergence of Klebsiella pneumoniae with Reduced Susceptibility Against Third Generation Cephalosporins and Carbapenems in Lagos Hospitals, Nigeria.

Authors:  Kabiru O Akinyemi; Rebecca O Abegunrin; Bamidele A Iwalokun; Christopher O Fakorede; Oliwia Makarewicz; Heinrich Neubauer; Mathias W Pletz; Gamal Wareth
Journal:  Antibiotics (Basel)       Date:  2021-02-01

8.  CPO Complete, a novel test for fast, accurate phenotypic detection and classification of carbapenemases.

Authors:  Gina K Thomson; Sameh AbdelGhani; Kenneth S Thomson
Journal:  PLoS One       Date:  2019-12-11       Impact factor: 3.240

9.  NDM Production as a Dominant Feature in Carbapenem-Resistant Enterobacteriaceae Isolates from a Tertiary Care Hospital.

Authors:  Fakhur Uddin; Syed Hadi Imam; Saeed Khan; Taseer Ahmed Khan; Zulfiqar Ahmed; Muhammad Sohail; Ashraf Y Elnaggar; Ahmed M Fallatah; Zeinhom M El-Bahy
Journal:  Antibiotics (Basel)       Date:  2021-12-31

10.  Complete Genome Sequence of the First KPC-Type Carbapenemase-Positive Proteus mirabilis Strain from a Bloodstream Infection.

Authors:  Vincenzo Di Pilato; Adriana Chiarelli; Christine J Boinett; Eleonora Riccobono; Simon R Harris; Marco Maria D'Andrea; Nicholas R Thomson; Gian Maria Rossolini; Tommaso Giani
Journal:  Genome Announc       Date:  2016-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.